TNXP: Tonix Pharmaceuticals Holding Corp Company Profile & Statistics

About

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102, for the management of fibromyalgia syndrome and TNX-105 to treat symptoms of post-traumatic stress disorder. Tonix Pharmaceuticals Holding Corp. is headquartered in New York.

Info & Links

CEO

Seth Lederman

Headquarters

26 MAIN STREET, SUITE 101
CHATHAM, NJ 07928, UNITED STATES

Auditor

EISNERAMPER LLP

Share holders

228

Employees

Tonix Pharmaceuticals Holding Corp Statistics

Valuation Measures

Market Capitalization²

71.19M

Enterprise Value

50.95M

Enterprise Value/EBITDA(ttm)

-0.37

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

10.12

Price to Book(mrq)

1.28

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

15.72%

Operating Margin(ttm)

-1197.86%

Profit Margin(ttm)

-1349.07%

Return on Equity(ttm)

-163.95%

Return on Invested Capital(ttm)

-220.25%

Return on Assets(ttm)

-118.88%

Income Statement

Revenue(ttm)

11.29M

Revenue Per Share(ttm)

0.06

Gross Profit(ttm)

2.34M

EBITDA(ttm)³

-136.72M

Net Income Available to Common(ttm)

-135.25M

Diluted EPS(ttm)

-52.74

Share Statistics

Beta (5Y Monthly)

2.23

52-Week Change

-97.49%

S&P 500 52-Week Change

26.50%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

186.89M

Dividend Yield

0.00%

Float⁴

186.82M

% Held by Insiders

0.04%

% Held by Institutions

82.26%

Balance Sheet

Total Cash(mrq)

28.23M

Total Cash Per Share(mrq)

0.15

Total Debt(mrq)

7.99M

Total Debt/Equity(mrq)

10.77%

Current Ratio(mrq)

3.33%

Quick Ratio(mrq)

2.81%

Book Value Per Share(mrq)

0.48

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.75

Free Cash Flow(ytd)

-46.41M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

TNXP

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp Profile